Skip to content
2000
Volume 21, Issue 10
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

The control of blood pressure (BP) is a challenge in diabetic patients and is associated with adverse outcomes of diabetes. In this systematic review and meta-analysis, we investigated the BP control rate among hypertensive diabetic patients in the Eastern Mediterranean Region (EMR) countries.

Methods

We systematically searched PubMed, Scopus, Embase, Cochrane, and Web of Science databases up to January 2023 for observational studies on BP control among hypertensive diabetic patients in all EMR countries. We included studies reporting the proportion of hypertensive, type 2 diabetic patients with controlled BP, defined as systolic/diastolic BP < 140/90 or <130/80 mmHg. Study quality was assessed using modified STROBE guidelines, and a random-effect meta-analysis was conducted to pool prevalence data and calculate overall rates. Subgroup analysis was performed by gender, study design, country, and BP control cut-offs (140/90 and 130/80).

Results

Among the 1949 retrieved studies, 20 studies assessing 27956 individuals were included. The proportion of BP control regardless of cut-off points was 36.8% (95% CI=29.1%45.3%) based on the studies reported for both genders. The prevalence was 53.2% (95% CI=36.1%-69.6%) and 43.5% (95% CI=20.0%-70.3%) based on the studies reported just for women or men, respectively.

Conclusion

Our findings indicate that BP control targets are not successfully achieved in hypertensive diabetic patients in the Eastern Mediterranean region. It is recommended to place greater emphasis on the quality of hypertension care in the management of type 2 diabetes.

© 2025 The Author(s).
Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998327293240729080250
2024-07-31
2025-09-09

  • From This Site

    /content/journals/cdr/10.2174/0115733998327293240729080250
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cdr/21/10/CDR-21-10-08.html?itemId=/content/journals/cdr/10.2174/0115733998327293240729080250&mimeType=html&fmt=ahah

References

  1. Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A. Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases.J. Phys. Act. Health2011812735
     [Google Scholar]
  2. Global REGIONALGlobal, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021.Lancet202340210397203234
     [Google Scholar]
  3. Idf DiabetesA.T.L.A.S. IDF diabetes atlas2021https://diabetesatlas.org/atlas/tenth-edition/2023.
     [Google Scholar]
  4. ChenG. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.Hypertension2011575891897
     [Google Scholar]
  5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet1998352913183785310.1016/S0140‑6736(98)07019‑6 9742976
     [Google Scholar]
  6. Improving health outcomes of people with diabetes: target setting for the who global diabetes compact.Lancet20234011038413021312
     [Google Scholar]
  7. BerrahoM. El AchhabY. BenslimaneA. El RhaziK. ChikriM. NejjariC. Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study).Pan Afr. Med. J.20121152 22593788
     [Google Scholar]
  8. El-ShazlyM. Care-related risk factors for chronic diabetic complications in developing countries.Egypt Public Health20021165289296
     [Google Scholar]
  9. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ202137
     [Google Scholar]
  10. WHOWHO EMROhttps://www.emro.who.int/countries.html
  11. HIGGINS JPT.Measuring inconsistency in meta-analyses bmj2003327741455760
     [Google Scholar]
  12. EggerM. Bias in meta-analysis detected by a simple, graphical test.BMJ19973157109629634
     [Google Scholar]
  13. AdnanM. NoorW. BaigM.M.A. Risk factors of previously undiagnosed and known untreated hypertension among patients with Type-2 diabetes mellitus.Pak. J. Med. Sci.2023392361366
     [Google Scholar]
  14. AkhterJ AhmedA MawaniM LakhaniL KalsekarA Patterns, control and complications of diabetes from a hospital based registry established in a low income countryEndocr Disord201717130
     [Google Scholar]
  15. 2012
  16. Control of risk factors for cardiovascular disease among adults with previously diagnosed type 2 diabetes mellitus: a descriptive study from a middle eastern arab population.Open Cardiovasc. Med. J.2017133140
     [Google Scholar]
  17. AlkandariA. HbA1c, blood pressure, and cholesterol control in adults with diabetes: A report card for Kuwait.J. Diabetes Investig.202220221017321739
     [Google Scholar]
  18. AlwakeelJ.S. Al-SuwaidaA. IsnaniA.C. Al-HarbiA. AlamA. Concomitant macro and microvascular complications in diabetic nephropathy.Saudi J. Kidney Dis. Transpl.2009203402409 19414942
     [Google Scholar]
  19. ArshadA.R. TipuH.N. ParachaA.I. The impact of hypertension on lipid parameters in type 2 diabetes.J. Pak. Med. Assoc.2016661012621266 27686300
     [Google Scholar]
  20. BINAQEELAS Resistant hypertension in patients with type-2 diabetes mellitus: a single-center, cross-sectional study.Cureus2022141030228
     [Google Scholar]
  21. BonakdaranS. EbrahimzadehS. NoghabiS.H. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran.East. Mediterr. Health J.201117964064610.26719/2011.17.9.640 22259913
     [Google Scholar]
  22. El-ShafieK. RizviS. Control Of Hypertension Among Type IiDiabetics Oman MedJ. Control of hypertension among type ii diabeticsOMAN MED. J.2010323610
     [Google Scholar]
  23. EledrisiM. AlhajB. RehmaniR. AlotaibiM. MustafaM. Quality of diabetes care in Saudi Arabia.Diabetes Res. Clin. Pract.2007781145146
     [Google Scholar]
  24. EsteghamatiA. LarijaniB. Diabetes in Iran: prospective analysis from first nationwide diabetes report of national program for prevention and control of diabetes (NPPCD-2016).Sci. Rep.20177113461
     [Google Scholar]
  25. MansourA.A. Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study.Open Cardiovasc Med201266871
     [Google Scholar]
  26. MohammadA. AbujbaraM. AlshraidehJ. JaddouH. AjlouniK. The prevalence of resistant hypertension among type 2 diabetic patients attending the national center for diabetes, endocrinology, and genetics.J Endocro Metabol2017
     [Google Scholar]
  27. Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan.Ann. Saudi Med.2008285V-51
     [Google Scholar]
  28. RabizadehS. GholamiB. Mahmoudzadeh KaniS. RajabA. FarrokhpourH. Uncontrolled hypertension in patients with type 2 diabetes: what are the correlates.J. Clin. Hypertens.2021917761785
     [Google Scholar]
  29. SALAMEHAB The prevalence of hypertension and its progression among patients with type 2 diabetes in Jordan.Ann. Med. Surg.202273103162
     [Google Scholar]
  30. SoubraL. NureddinH. Factors associated with hypertension prevalence and control among lebanese type 2 diabetic patients.Int. J. Phar. Pharmacue. Sci.2016810153159
     [Google Scholar]
  31. KintscherU. Benefit of blood pressure control in diabetic patients.Curr. Hypertens. Rep.20151775010.1007/s11906‑015‑0561‑1 26068653
     [Google Scholar]
  32. CavenderM.A. WirkaR.C. Blood pressure lowering in the prevention of type 2 diabetes.Lancet2021398103131778177910.1016/S0140‑6736(21)02340‑0 34774133
     [Google Scholar]
  33. EmdinC.A. RahimiK. NealB. CallenderT. PerkovicV. PatelA. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.JAMA2015313660361510.1001/jama.2014.18574 25668264
     [Google Scholar]
  34. AdamS.K. DasS. JaarinK. A detailed microscopic study of the changes in the aorta of experimental model of postmenopausal rats fed with repeatedly heated palm oil.Int. J. Exp. Pathol.200990332132710.1111/j.1365‑2613.2009.00658.x 19563614
     [Google Scholar]
  35. SowersJR Recommendations For SpecialPOPULATIONS Recommendations for special populations: diabetes mellitus and the metabolic syndrome.Am J H200341S5S
     [Google Scholar]
  36. GROSSMANA. Blood pressure control in type 2 diabetic patientsCardiovas Diabetol20171613
     [Google Scholar]
  37. GybergV. De BacquerD. De BackerG. JenningsC. KotsevaK. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.Cardiovas. Diabetol.201514133
     [Google Scholar]
  38. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.Lancet2021
     [Google Scholar]
  39. HameedF. VisariaA. Ideas to further understand similarities and differences in blood pressure effects among various diets.J. Hypertens.202240240810.1097/HJH.0000000000002979 34992198
     [Google Scholar]
  40. VentriglioA. SancassianiF. ContuM.P. Mediterranean diet and its benefits on health and mental health: a literature review.Clin. Pract. Epidemiol. Ment. Health202016115616410.2174/1745017902016010156 33029192
     [Google Scholar]
  41. Al-RiyamiH. NadarS.K. Spotlight on hypertension in the Middle-East.J. Hum. Hypertens.2022365425427
     [Google Scholar]
  42. Turk-AdawiK. SarrafzadeganN. FadhilI. TaubertK. SadeghiM. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.Nat. Rev. Cardiol.2018152106119
     [Google Scholar]
  43. MoonJ.H. Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells.Exp. Mol. Med.2023551022692280
     [Google Scholar]
  44. MagkosF. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus.Nat. Rev. Endocrinol.20201610545555
     [Google Scholar]
  45. DefronzoR.A. InsulinR.E.S.I.S.T.A.N.C.E. Insulin resistance: a multifaceted syndrome responsible for niddmobesity, hypertension, dyslipidaemia and atherosclerosis.Neth. J. Med.1997505191197
     [Google Scholar]
  46. GuptaA.K. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.Diabetes Care2008315982988
     [Google Scholar]
  47. YasunoS. UeshimaK. ObaK. FujimotoA. HirataM. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the candesartan antihypertensive survival evaluation in japan (case-j) trial.Diabetes Care201033511221127
     [Google Scholar]
  48. LiuW. HigashikuniY. SataM. MELLITUS HypertensRES Optimizing antihypertensive therapy in patients with diabetes mellitus.Hypertens. Res.2023463797800
     [Google Scholar]
  49. SomaratneJ.B. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.Cardiovas. Diabet.201110129
     [Google Scholar]
  50. GovindS. SahaS. Impaired myocardial functional reserve in hypertension and diabetes mellitus without coronary artery disease: Searching for the possible link with congestive heart failure in the myocardial Doppler in diabetes (MYDID) study II.Am. J. Hypertens.2006198851857
     [Google Scholar]
  51. GrossmanE. High blood pressure and diabetes mellitus are all antihypertensive drugs created equal?.Arch. Intern. Med.20001602447245210
     [Google Scholar]
  52. AssmannG. SchulteH. The prospective cardiovascular münster (procam) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.Am. Heart J.19881161713172410
     [Google Scholar]
  53. YangYW CHADS2 scores as a predictor of ischemic stroke in patients with peripheral artery disease.Mayo Clin Proc2016914550(1)
     [Google Scholar]
  54. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.BMJ1998317716070371310.1136/bmj.317.7160.703 9732337
     [Google Scholar]
  55. HanssonL. ZanchettiA. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (hot) randomised trial. hot study group.Lancet19983511755176210
     [Google Scholar]
  56. PatelA. MacmahonS. ChalmersJ. NealB. WoodwardM. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the advance trial): a randomised controlled trial.Lancet200737082984010
     [Google Scholar]
  57. YusufS. Telmisartan, ramipril, or both in patients at high risk for vascular events.N. Engl. J. Med.2008358151547155910
     [Google Scholar]
  58. YusufS. Telmisartan to prevent recurrent stroke and cardiovascular events.N. Engl. J. Med.20083591225123710
     [Google Scholar]
  59. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.JAMA201030416168
     [Google Scholar]
  60. BrunströmM. CarlbergB. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.BMJ2016352717
     [Google Scholar]
  61. CarlbergB. LeivaViriam M WrightJames. Blood pressure targets for hypertension in people with diabetes mellitus.Cochrane Database Syst. Rev.20132013108277
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998327293240729080250
Loading
Blood Pressure Control Among Diabetic Patients in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis
Curr. Diabetes Rev. 21, E310724232514 (2025); https://doi.org/10.2174/0115733998327293240729080250
/content/journals/cdr/10.2174/0115733998327293240729080250
/content/journals/cdr/10.2174/0115733998327293240729080250
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article. The PRISMA and modified STROBE checklists are available as supplementary materials on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): blood pressure; chronic metabolic disorder; Diabetes; health policy; health promotion; hypertension

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test